BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

4 hedge funds and large institutions have $464K invested in ProShares UltraShort NASDAQ Biotechnology in 2025 Q1 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$109K
2
+$19

Top Sellers

1
-$704K
2
-$27K
3
-$1.55K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$390K
TRCT
2
Tower Research Capital (TRC)
New York
$72.2K
Morgan Stanley
3
Morgan Stanley
New York
$1.42K
UBS Group
4
UBS Group
Switzerland
$19
Jane Street
5
Jane Street
New York
–
Citigroup
6
Citigroup
New York
–